Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Among patients with chronic insomnia, transcutaneous auricular vagus nerve stimulation improves sleep quality and is safe and effective.

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

Nonoperative treatment, such physical therapy, is the typical approach to treating rotator-cuff tears. However, surgery is considered in certain patients whose rotator-cuff tears don't resolve with ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

A new painkiller was approved by the Food and Drug Administration (FDA) on Thursday, and is one step closer to making its way ...

Yoga can help relieve sciatica pain and even prevent it from returning, as it helps improve spinal alignment and release tension. Here are the poses that help the most.

The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...